Communication about the Risks and Benefits of Phase I Pediatric Oncology Trials

INTRODUCTION: Phase 1 pediatric oncology trials offer only a small chance of direct benefit and may have significant risks and an impact on quality of life. To date, research has not examined discussions of risks and benefits during informed consent conferences for phase 1 pediatric oncology trials....

Descripción completa

Detalles Bibliográficos
Autores principales: Hazen, Rebecca A., Zyzanski, Stephen, Baker, Justin, Drotar, Dennis, Kodish, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404031/
https://www.ncbi.nlm.nih.gov/pubmed/25638751
http://dx.doi.org/10.1016/j.cct.2015.01.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404031/
https://www.ncbi.nlm.nih.gov/pubmed/25638751
http://dx.doi.org/10.1016/j.cct.2015.01.015

Ejemplares similares